# Artificial Intelligence (AI)-Assisted Risk-based Prostate Cancer Detection

> **NCT05443412** · — · RECRUITING · sponsor: **Chinese University of Hong Kong** · enrollment: 510 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **DIAGNOSTIC_TEST:** Diagnostic test for prostate cancer

## Key facts

- **NCT ID:** NCT05443412
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-08-01
- **Primary completion:** 2026-07-31
- **Final completion:** 2026-10-30
- **Target enrollment:** 510 (ESTIMATED)
- **Last updated:** 2025-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05443412

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05443412, "Artificial Intelligence (AI)-Assisted Risk-based Prostate Cancer Detection". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT05443412. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*